2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES
The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Holland, Sacha J Clough, Jeffrey Li, Hui Bhamidipati, Somasekhar Singh, Rajinder Rossi, Alexander B Sylvain, Catherine Argade, Ankush Payan, Donald Keim, Holger Molineaux, Susan |
| description | The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in the treatment and prevention of diseases characterized by, caused by or associated with the release of chemical mediators via degranulation and other processes effected by activation of the IgE and/or IgG receptor signaling cascades. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2020085820A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2020085820A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2020085820A13</originalsourceid><addsrcrecordid>eNrjZNAz0jHRDYgM8vT1dPH0c3XxdPQFUgrO_r4B_qF-LsEKjn4uCiEerp5BCqHBrsE8DKxpiTnFqbxQmptB2c01xNlDN7UgPz61uCAxOTUvtSQ-NNjIwMjAwMLUwsjA0dCYOFUAYbEmdg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES</title><source>esp@cenet</source><creator>Holland, Sacha J ; Clough, Jeffrey ; Li, Hui ; Bhamidipati, Somasekhar ; Singh, Rajinder ; Rossi, Alexander B ; Sylvain, Catherine ; Argade, Ankush ; Payan, Donald ; Keim, Holger ; Molineaux, Susan</creator><creatorcontrib>Holland, Sacha J ; Clough, Jeffrey ; Li, Hui ; Bhamidipati, Somasekhar ; Singh, Rajinder ; Rossi, Alexander B ; Sylvain, Catherine ; Argade, Ankush ; Payan, Donald ; Keim, Holger ; Molineaux, Susan</creatorcontrib><description>The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in the treatment and prevention of diseases characterized by, caused by or associated with the release of chemical mediators via degranulation and other processes effected by activation of the IgE and/or IgG receptor signaling cascades.</description><language>eng</language><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200319&DB=EPODOC&CC=US&NR=2020085820A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,782,887,25571,76555</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200319&DB=EPODOC&CC=US&NR=2020085820A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Holland, Sacha J</creatorcontrib><creatorcontrib>Clough, Jeffrey</creatorcontrib><creatorcontrib>Li, Hui</creatorcontrib><creatorcontrib>Bhamidipati, Somasekhar</creatorcontrib><creatorcontrib>Singh, Rajinder</creatorcontrib><creatorcontrib>Rossi, Alexander B</creatorcontrib><creatorcontrib>Sylvain, Catherine</creatorcontrib><creatorcontrib>Argade, Ankush</creatorcontrib><creatorcontrib>Payan, Donald</creatorcontrib><creatorcontrib>Keim, Holger</creatorcontrib><creatorcontrib>Molineaux, Susan</creatorcontrib><title>2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES</title><description>The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in the treatment and prevention of diseases characterized by, caused by or associated with the release of chemical mediators via degranulation and other processes effected by activation of the IgE and/or IgG receptor signaling cascades.</description><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAz0jHRDYgM8vT1dPH0c3XxdPQFUgrO_r4B_qF-LsEKjn4uCiEerp5BCqHBrsE8DKxpiTnFqbxQmptB2c01xNlDN7UgPz61uCAxOTUvtSQ-NNjIwMjAwMLUwsjA0dCYOFUAYbEmdg</recordid><startdate>20200319</startdate><enddate>20200319</enddate><creator>Holland, Sacha J</creator><creator>Clough, Jeffrey</creator><creator>Li, Hui</creator><creator>Bhamidipati, Somasekhar</creator><creator>Singh, Rajinder</creator><creator>Rossi, Alexander B</creator><creator>Sylvain, Catherine</creator><creator>Argade, Ankush</creator><creator>Payan, Donald</creator><creator>Keim, Holger</creator><creator>Molineaux, Susan</creator><scope>EVB</scope></search><sort><creationdate>20200319</creationdate><title>2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES</title><author>Holland, Sacha J ; Clough, Jeffrey ; Li, Hui ; Bhamidipati, Somasekhar ; Singh, Rajinder ; Rossi, Alexander B ; Sylvain, Catherine ; Argade, Ankush ; Payan, Donald ; Keim, Holger ; Molineaux, Susan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2020085820A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2020</creationdate><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Holland, Sacha J</creatorcontrib><creatorcontrib>Clough, Jeffrey</creatorcontrib><creatorcontrib>Li, Hui</creatorcontrib><creatorcontrib>Bhamidipati, Somasekhar</creatorcontrib><creatorcontrib>Singh, Rajinder</creatorcontrib><creatorcontrib>Rossi, Alexander B</creatorcontrib><creatorcontrib>Sylvain, Catherine</creatorcontrib><creatorcontrib>Argade, Ankush</creatorcontrib><creatorcontrib>Payan, Donald</creatorcontrib><creatorcontrib>Keim, Holger</creatorcontrib><creatorcontrib>Molineaux, Susan</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Holland, Sacha J</au><au>Clough, Jeffrey</au><au>Li, Hui</au><au>Bhamidipati, Somasekhar</au><au>Singh, Rajinder</au><au>Rossi, Alexander B</au><au>Sylvain, Catherine</au><au>Argade, Ankush</au><au>Payan, Donald</au><au>Keim, Holger</au><au>Molineaux, Susan</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES</title><date>2020-03-19</date><risdate>2020</risdate><abstract>The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in the treatment and prevention of diseases characterized by, caused by or associated with the release of chemical mediators via degranulation and other processes effected by activation of the IgE and/or IgG receptor signaling cascades.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2020085820A1 |
| source | esp@cenet |
| subjects | ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T22%3A28%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Holland,%20Sacha%20J&rft.date=2020-03-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2020085820A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |